Cathie Wood's Buying Beam Therapeutics -- Should You?
Over the past year, shares of Beam Therapeutics (NASDAQ: BEAM) have soared over 174% higher. Investors of all stripes want to know if this stock can keep climbing, or if it's already too late to ride the wave.
This biotech didn't make its market debut until last year, but it's already a major holding for ARK Invest. This is the firm founded and still run by Cathie Wood, one of the world's most famous investors. Before getting into the risks, let's look at reasons Wood can't seem to get enough of this stock.
Image source: Getty Images.
Source Fool.com
